Table of Contents
1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antihypertensive Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Diuretics
1.2.3 Angiotensin receptorblockers (ARBs)
1.2.4 Angiotensin converting enzyme (ACE) inhibitors
1.2.5 Beta blockers
1.2.6 Alpha blockers
1.2.7 Calcium channel blockers
1.2.8 Renin inhibitors
1.2.9 Vasodilators
1.3 Market Analysis by Application
1.3.1 Overview: Global Antihypertensive Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hosptial
1.3.3 Clinic
1.3.4 Home
1.4 Overview of Global Antihypertensive Market
1.4.1 Global Antihypertensive Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Astra Zeneca
2.2.1 Astra Zeneca Details
2.2.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Astra Zeneca SWOT Analysis
2.2.4 Astra Zeneca Product and Services
2.2.5 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ranbaxy
2.7.1 Ranbaxy Details
2.7.2 Ranbaxy Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ranbaxy SWOT Analysis
2.7.4 Ranbaxy Product and Services
2.7.5 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lupin
2.8.1 Lupin Details
2.8.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lupin SWOT Analysis
2.8.4 Lupin Product and Services
2.8.5 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Daiichi Sankyo SWOT Analysis
2.10.4 Daiichi Sankyo Product and Services
2.10.5 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Manufacturer Market Share in 2019
3.3.2 Top 6 Antihypertensive Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antihypertensive Revenue and Market Share by Regions (2015-2020)
4.2 North America Antihypertensive Sales and Growth Rate (2015-2020)
4.3 Europe Antihypertensive Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antihypertensive Sales and Growth Rate (2015-2020)
4.5 South America Antihypertensive Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antihypertensive Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antihypertensive Sales, Revenue and Market Share by Country
5.1.1 North America Antihypertensive Sales and Market Share by Country (2015-2020)
5.1.2 North America Antihypertensive Revenue and Market Share by Country (2015-2020)
5.2 United States Antihypertensive Sales and Growth Rate (2015-2020)
5.3 Canada Antihypertensive Sales and Growth Rate (2015-2020)
5.4 Mexico Antihypertensive Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antihypertensive Sales, Revenue and Market Share by Country
6.1.1 Europe Antihypertensive Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antihypertensive Revenue and Market Share by Country (2015-2020)
6.2 Germany Antihypertensive Sales and Growth Rate (2015-2020)
6.3 UK Antihypertensive Sales and Growth Rate (2015-2020)
6.4 France Antihypertensive Sales and Growth Rate (2015-2020)
6.5 Russia Antihypertensive Sales and Growth Rate (2015-2020)
6.6 Italy Antihypertensive Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antihypertensive Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antihypertensive Revenue and Market Share by Regions (2015-2020)
7.2 China Antihypertensive Sales and Growth Rate (2015-2020)
7.3 Japan Antihypertensive Sales and Growth Rate (2015-2020)
7.4 Korea Antihypertensive Sales and Growth Rate (2015-2020)
7.5 India Antihypertensive Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antihypertensive Sales and Growth Rate (2015-2020)
7.7 Australia Antihypertensive Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antihypertensive Sales, Revenue and Market Share by Country
8.1.1 South America Antihypertensive Sales and Market Share by Country (2015-2020)
8.1.2 South America Antihypertensive Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antihypertensive Sales and Growth Rate (2015-2020)
8.3 Argentina Antihypertensive Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antihypertensive Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antihypertensive Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antihypertensive Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antihypertensive Sales and Growth Rate (2015-2020)
9.3 Turkey Antihypertensive Sales and Growth Rate (2015-2020)
9.4 Egypt Antihypertensive Sales and Growth Rate (2015-2020)
9.5 South Africa Antihypertensive Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antihypertensive Sales and Market Share by Type (2015-2020)
10.2 Global Antihypertensive Revenue and Market Share by Type (2015-2020)
10.3 Global Antihypertensive Price by Type (2015-2020)
11 Global Antihypertensive Market Segment by Application
11.1 Global Antihypertensive Sales Market Share by Application (2015-2020)
11.2 Global Antihypertensive Revenue Market Share by Application (2015-2020)
11.3 Global Antihypertensive Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2021-2025)
12.2 Antihypertensive Market Forecast by Regions (2021-2025)
12.2.1 North America Antihypertensive Market Forecast (2021-2025)
12.2.2 Europe Antihypertensive Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antihypertensive Market Forecast (2021-2025)
12.2.4 South America Antihypertensive Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antihypertensive Market Forecast (2021-2025)
12.3 Antihypertensive Market Forecast by Type (2021-2025)
12.3.1 Global Antihypertensive Sales Forecast by Type (2021-2025)
12.3.2 Global Antihypertensive Market Share Forecast by Type (2021-2025)
12.4 Antihypertensive Market Forecast by Application (2021-2025)
12.4.1 Global Antihypertensive Sales Forecast by Application (2021-2025)
12.4.2 Global Antihypertensive Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Pfizer、Astra Zeneca、Merck、Novartis、Johnson & Johnson、Sanofi、Ranbaxy、Lupin、Boehringer Ingelheim、Daiichi Sankyo
【免責事項】
https://www.globalresearch.jp/disclaimer